RESTEM Information, Including Revenue, Investors, Funding, Competitors & Key Metrics

RESTEM is a leading clinical-stage biotechnology company focused on developing off-the-shelf, next-generation cell therapies designed to modulate the immune system. Leveraging our proprietary products, robust clinical development expertise, and cutting-edge-manufacturing capabilities, we advance two potentially groundbreaking programs, umbilical cord lining stem cells (ULSCs) for auto-immune diseases and natural killer cell (NK) therapeutics targeting senescence and age-associated disorders. OurView more